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Purpose. To compare anterior eye segment measurements and morphology obtained with two optical coherence tomography
systems (TD OCT, SS OCT) in eyes with corneal dystrophies (CDs). Methods. Fifty healthy volunteers (50 eyes) and 54 patients
(96 eyes) diagnosed with CD (epithelial basement membrane dystrophy, EBMD = 12 eyes; Thiel-Behnke CD = 6 eyes; lattice CD
TGFBI type = 15 eyes; granular CD type 1 = 7 eyes, granular CD type 2 = 2 eyes; macular CD = 23 eyes; and Fuchs endothelial
CD = 31 eyes) were recruited for the study. Automated and manual central corneal thickness (aCCT, mCCT), anterior chamber
depth (ACD), and nasal and temporal trabecular iris angle (nTIA, tTIA) were measured and compared with Bland-Altman plots.
Results.Good agreement between theTDand SSOCTmeasurementswas demonstrated formCCTand aCCT in normal individuals
and for mCCT in the CDs group. The ACD, nTIA, and tTIA measurements differed significantly in both groups. TBCD, LCD,
and FECD caused increased CCT. MCD caused significant corneal thinning. FECD affected all analyzed parameters. Conclusions.
Better agreement between SS OCT and TD OCT measurements was demonstrated in normal individuals compared to the CDs
group. OCT provides comprehensive corneal deposits analysis and demonstrates the association of CD with CCT, ACD, and TIA
measurements.
1. Introduction
Corneal dystrophy (CD) is a group of inherited, bilateral,
symmetric, slowly progressive corneal diseases without any
relationship to environmental or systemic factors.
Noninvasive evaluation of anterior eye segment mea-
surements is pertinent for the diagnosis of several corneal
dystrophies types as well as other ophthalmic diseases,
including glaucoma, keratoconus, and corneal degenerations,
and is essential in planning corneal surgical and refractive
procedures.
Optical coherence tomography (OCT), first introduced
in 1991, is a high-speed, high-resolution, noncontact imaging
technique developed for noninvasive cross-sectional imaging
in biological systems [1]. The OCT technology has evolved
from time-domain (TD OCT) to spectral-domain (SD OCT)
and swept-source OCT (SS OCT). Anterior eye segment
imaging with the 830 nm light wavelength TD OCT was
demonstrated in 1994 [2]. Changing the light wavelength
from 830 nm to 1310 nm allowed transscleral imaging with
the scleral spur assessment [3]. TD OCT technology has a
longitudinal resolution of 18 𝜇m and a transverse resolution
of 60𝜇m. It provides scans at a rate of up to 2048 A
scans per sec. SD OCT, introduced in 2002, has an axial
resolution of 5.0 𝜇m and a transverse resolution of 15𝜇m
[4, 5]. It scans at 26,000 A scans per sec and provides
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an increased signal-to-noise ratio and increased robustness
compared with TDOCT [6]. SS OCT uses a monochromatic,
tunable, fast-scanning laser source and a photodetector to
detect wavelength-resolved interference signals [7, 8]. Com-
mercially available SS OCT was introduced in 2008. It uses
a swept-source laser wavelength of 1310 nm, scans up to
30,000 A scans per sec, and has longitudinal and transverse
resolutions of 10 𝜇m and 30 𝜇m, respectively. The advantage
of SSOCT is the simultaneous acquisition of numerous scans,
which provides the possibility of creating a 3-dimensional
corneal, anterior eye segment, or gonioscopy views. That
feature could be especially important in eyes with corneal
opacities to gain the possibility of creating a 3D pattern of the
corneal changes.
OCT has been proven to provide reliable measurements
of anterior eye segment parameters characterized by good
repeatability and reproducibility [9–13]. Most SS OCT mor-
phometry studies are based on normal subjects, with the
exception of anterior chamber angle parameters in glaucoma-
tous eyes [14–16] and corneal thickness measurements in ker-
atoconic eyes [17, 18]. Currently, there are no data on anterior
eye segment measurements with SS OCT in various corneal
dystrophies. Previous papers on OCT imaging focused on
describing corneal morphology features in different CDs
[19–23]. The SS OCT was proved useful in planning of
the phototherapeutic keratectomy to treat granular corneal
dystrophy by determining the size, depth, and location of
deposits based on the case report study [24]. The authors
present a comprehensive, observational, comparative study
of corneal thickness, anterior chamber depth, and trabecular
iris angle measurements with TD OCT and SS OCT in
eyes with corneal dystrophies compared to normal controls.
Agreement between the TDOCT and SSOCTmeasurements
is assessed.
2. Material and Methods
The study was conducted in accordance with the ethical
standards stated in the 1964 Declaration of Helsinki and was
approved by the Ethics Committee of the Medical University
of Silesia, Katowice, Poland (KNE/0022/KB1/43/I/14). All
patients had to sign informed consent before any study
procedure.
Fifty healthy volunteers (50 eyes) and 54 patients (96
eyes) diagnosed with various corneal dystrophies (epithelial
basement membrane dystrophy, EBMD = 12 eyes; Thiel-
Behnke corneal dystrophy, TBCD = 6 eyes; lattice corneal
dystrophy TGFBI type, LCD1 = 15 eyes; granular corneal
dystrophy type 1, GCD1 = 7 eyes; granular corneal dystrophy
type 2, GCD2 = 2 eyes; macular corneal dystrophy,MCD= 23
eyes; Fuchs endothelial corneal dystrophy, FECD = 31 eyes)
were recruited for the study.
The inclusion criteria for the healthy subjects group were
as follows: best corrected visual acuity of 20/20, refractive
error less than or equal to ±3.0D, and no history of ocular
disease or surgery. The mean age of the subjects was 30 ±
7 years; there were 30 women and 20 men. The inclusion
criteria for the study group included the clinical diagnosis
of corneal dystrophy and no history of ocular surgery. The
exclusion criterion was the presence of other ophthalmic or
systemic diseases affecting corneal morphology. The mean
age of the patients was 49 ± 16 years; there were 39 women
and 15 men. 12 eyes of 12 patients with diagnosis of CD
underwent keratoplasty procedures; therefore the eyes were
excluded from the study group. The healthy subjects and
the study group patients were age matched for all CD types,
except for FECD. Patients with FECD were on average 15 ± 9
years older. The diagnosis of EBMD and FECD was based on
the clinical examination (slit-lamp biomicroscopy andOCT).
Thediagnosis of all patientswithTBCD, LCD1,GCD1,GCD2,
and MCD was confirmed with genetic sequencing of TGFBI
and CHST6 genes according to the methodology presented
in previous author’s publications [22, 23]. In the CD group
eyes with differentiated severity of the disease were included
in the analysis.
Clinical examination consisted of visual acuity, slit-lamp
biomicroscopy with photography (magnification 10x; 16x),
anterior eye segment time-domain, and spectral swept-
source optical coherence tomography.
Anterior segment imaging was performed by one
observer. We used two anterior segment optical coherence
systems: 1310 nm time-domain OCT (TD OCT; Visante
OCT; Carl Zeiss Meditec, Inc., Dublin, California, USA)
and 1310 nm swept-source spectral-domain OCT (SS OCT;
Casia SS-1000 OCT; Tomey, Nagoya, Japan). During the TD
OCT exam, we used anterior segment (16 × 6mm; 2 × 256 A
scans), high-resolution corneal quad scans (10 × 3mm; 4 ×
512 A scans), and an automatic pachymetry map (8 × 128 A
scans).
During the SS OCT exam, we used the anterior chamber
angle (16 × 6mm; 64 × 512 A scans) and cornea (10 × 4mm;
16 × 512 A scans) protocols.
Automated and manual central corneal thickness (aCCT,
mCCT), anterior chamber depth (ACD), and nasal and
temporal trabecular iris angle (nTIA, tTIA) were measured.
The analysis of the measurement results was performed
by three observers. ACD was defined as the perpendicular
distance from the corneal endothelium at the corneal apex
to the anterior lens surface. TIA was defined as an angle
measured with the apex in the iris recess and the arms of the
angle passing through a point on the trabecular meshwork
500𝜇m from the scleral spur and the point on the iris
perpendicularly opposite [25]. In four eyes from the study
group, we could not assess the scleral spur, so they were
excluded from the TIA assessment. Corneal morphology
assessment was performed and compared between TD OCT
and SS OCT.We analyzed the characteristic features, pattern,
and location of CD deposits.
Mean values and standard deviation (SD) were calculated
for each parameter in the groups with more than 30 eyes (the
control group, FECD).Median and rangewere assessed in the
groups with fewer than 30 eyes (EBMD, TBCD, LCD, GCD1,
GCD2, and MCD). The values for the parameters were com-
pared between the normal and CDs groups using Student’s
t-test or the Mann-Whitney U test depending on the sample
size. Agreement between pairs ofmeasurementswas analyzed
with Bland-Altman plots. The 95% limit of agreement (mean
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Table 1: Results of automated andmanual central corneal thickness (aCCT, mCCT), anterior chamber depth (ACD), and nasal and temporal
trabecular iris angle (nTIA, tTIA)measurements by swept-source optical coherence tomography SS OCT and time-domain optical coherence
tomography TD OCT. Values were calculated as mean ± standard deviation (SD) or median and range depending on the sample size (<30 or
≥30). BCVA results were presented as range for all groups. EBMD= epithelial basement membrane dystrophy, TBCD=Thiel-Behnke corneal
dystrophy, LCD1 = lattice corneal dystrophy TGFBI type, GCD1 = granular corneal dystrophy type 1, GCD2 = granular corneal dystrophy
type 2, MCD = macular corneal dystrophy, and FECD = Fuchs endothelial corneal dystrophy.
Parameter OCT device Control group Study group
CD type EBMD TBCD LCD GCD1 GCD2 MCD FECD
Number of
eyes 50 eyes 12 eyes 6 eyes 15 eyes 7 eyes 2 eyes 23 eyes 31 eyes
BCVA 1.0 1.0 0.3–0.9 0.1–0.5 0.05–0.8 0.5–0.6 0.05–0.2 0.05–0.4
aCCT
[𝜇m]
TD OCT 548.96 545 600 583 550 538.5 459 675.54
±37.34 524–586 587–615 550–620 498–567 529–548 414–492 ±42.19
SS OCT 553.96 554.5 598.5 587 546 528 453 682.03
±31.91 518–600 578–620 546–619 480–583 518–538 419–502 ±41.38
mCCT
[𝜇m]
TD OCT 546.94 541.5 602 588 555 530 456 676.03
±31.13 517–582 587–618 528–610 490–578 520–540 417–503 ±43.13
SS OCT 550.34 553.5 599.5 593 550 513 447 675.45
±31.13 507–580 580–625 550–621 498–576 507–519 418–508 ±52.98
ACD
[mm]
TD OCT 3.0514 3.085 2.9 3.13 3.11 3.22 3.05 2.30
±0.24 2.71–3.45 2.71–3.15 2.71–3.59 2.72–3.24 3.06–3.39 2.61–3.59 ±0.35
SS OCT 2.9718 2.955 2.91 3.015 2.98 3.18 2.98 2.36
±0.25 2.61–3.38 2.61–3.05 2.61–3.59 2.68–3.05 3.01–3.36 2.69–3.59 ±0.46
nTIA
[
∘
]
TD OCT 31.44 31 27 30 33 33 31 21.38
±4.98 24–39 24–32 24–47 29–38 30–36 24–41 ±4.40
SS OCT 33.02 33.5 26.5 33 34 30.5 32 19.61
±5.67 22–42 22–39 26–47 32–42 27–34 20–42 ±4.49
tTIA
[
∘
]
TD OCT 29.9 27.5 27 29 32 30 30 19.38
±5.81 22–42 23–34 22–39 29–41 26–34 24–37 ±5.33
SS OCT 32.12 31.5 30 33 34 32.5 31 20.29
±5.57 24–44 24–36 23–40 30–40 29–36 24–41 ±6.01
difference ±1.96 standard deviation) was calculated. A p value
of less than .05 was considered statistically significant.
3. Results
Mean, standard deviation, and median and range values of
aCCT, mCCT, ACD, nTIA, and tTIA for the control and CDs
groups are presented in Table 1.
3.1. Agreement of aCCT, mCCT, ACD, nTIA, and tTIA Mea-
surements. Mean difference in the aCCT measurements by
TD OCT and SS OCT was not statistically significant in
the control group (𝑝 = .14) but was significant in the CD
group (𝑝 = .04). The aCCT measured with SS OCT was on
average 4.4 𝜇m higher than that measured with TD OCT in
the control group and 4.32 𝜇m in the CDs group. The mCCT
measurements demonstrated the best agreement between TD
OCT and SSOCTwith no significant difference in the control
group (𝑝 = .12) and the CDs group (𝑝 = .14). The ACD
measured with SS OCT was on average 0.07mm lower than
that measured with TD OCT in the control group (𝑝 < .001)
and 0.06mm lower in the CDs group (𝑝 = .01). The mean
difference in the nTIA measurements was significant in both
groups, 𝑝 = .001 in the control group and 𝑝 = .03 in
the CDs group. The nTIA measured with SS OCT was 1.58∘
higher than thatmeasuredwith TDOCT in the control group
and 1.8∘ lower in the CDs group. The mean difference in the
tTIA measurements was also significant in both groups with
𝑝 < .001 in the control group and 𝑝 < .001 in the CDs
group.The tTIAmeasuredwith SSOCTwas 2.22∘ higher than
that measured with TD OCT in the control group and 1.97∘
higher in the CDs group. All data including mean difference,
95% confidence interval, standard deviation, and p value are
presented in Table 2. The Bland-Altman plots including the
95% limit of agreement are presented in Figure 1.
3.2. Control Group and CDs Group Measurements Compar-
ison. TD OCT and SS OCT measurements of aCCT and
mCCTwere significantly different in four corneal dystrophies
(TBCD, LCD, MCD, and FECD) compared to the control
group.
The aCCT and mCCT measurements were significantly
higher in TBCD, LCD, and FECD compared to normal
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Figure 1: Continued.
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Figure 1: The graphic presentation of Bland-Altman plot comparing measurements of TD OCT and SS OCT in control and corneal
dystrophies group (CD group). Dash-dot line: 95% CI: 95% confidence interval of the mean difference; dashed line: ±1.95 SD (standard
deviation); aCCT: automated central corneal thickness; mCCT: manual central corneal thickness; ACD: anterior chamber depth; nTIA: nasal
trabecular iris angle; tTIA: temporal trabecular iris angle.
Table 2: Bland-Altman plot comparing automated and manual central corneal thickness (aCCT, mCCT), anterior chamber depth (ACD),
and nasal and temporal trabecular iris angle (nTIA, tTIA) measurements by swept-source optical coherence tomography SS OCT and time-
domain optical coherence tomography TD OCT in control and corneal dystrophies group (CD group). 95% CI:95% confidence interval of
the mean difference; SD: standard deviation.
Control group CD group
Mean difference 95% CI SD 𝑝 Mean difference 95% CI SD 𝑝
aCCT −4.4 −10.47–1.63 21.29 .14 −4.32 −8.51–0.13 20.35 .04
mCCT −3.4 −7.7–0.97 15.37 .12 −3.75 −8.81–1.31 24.58 .14
ACD 0.07 0.06–0.09 0.06 <.001 0.06 −0.01–0.14 0.38 .01
nTIA −1.58 −2.48–−0.67 3.2 .001 1.8 0.14–3.47 6.62 .03
tTIA −2.22 −3.04–−0.39 2.91 <.001 −1.97 −2.59–−1.36 2.97 <.001
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(a)
(b)
Figure 2: Anterior segment single 0–180∘ scan of TD OCT with
measured results of following parameters: mCCT, ACD, nTIA, tTIA,
ATA, angle to angle distance, and CLR, crystalline lens rise. (a)
Control group. (b) FECD.Note the difference betweenmCCT, ACD,
nTIA, and tTIA, which is statistically significant (𝑝 < .0001).
individuals. In MCD, the analysis revealed lower CCT values
compared to the control group.
Themean values ± standard deviation andmedian values
(range) of aCCT andmCCT, ACD, nTIA, and tTIAmeasured
with TD OCT and SS OCT in the control and study group
were presented in Table 1.
FECD was the only CD that affected all analyzed anterior
eye chamber parameters (Figure 2). The aCCT, mCCT, ACD,
nTIA, and tTIAmeasurements in FECD differed significantly
from those for the control group (𝑝 < .001). The summary of
the comparison is presented in Table 3.
3.3. Corneal Morphology Comparison. All corneal character-
istic CD features revealed on the SS OCT scans were also
visible on the TD OCT scans. That makes both techniques
useful for establishing the diagnosis of each corneal dystro-
phy.The advantage of SSOCT is the simultaneous acquisition
of numerous scans, which provides the possibility of creating
a 3-dimensional corneal pattern of changes.
All corneal dystrophies deposits were hyperreflective on
the TD OCT and SS OCT scans, but the level of increased
reflectivity differed and extended from diffuse areas of
increased reflectivity in LCD to highly reflective corneal
opacities in GCD2. The opacities also differed in shape and
pattern depending on the CD type.
No changes in EBMDwere distinguishable on eitherOCT
scan. TBCD was characterized by increased reflectivity in
the Bowman layer and anterior corneal stroma (Figure 3).
The deposits caused the irregularity of the anterior stromal
border from the epithelium side forming a sawtooth pat-
tern of hyperreflective material. LCD caused diffuse areas
of increased reflectivity in the area of Bowman layer and
anterior to midstroma. GCD1 was characterized by focal
granular hyperreflective changes in the Bowman layer and
anterior to mid corneal stroma. Corneal deposits in GCD2
had the highest reflectivity; there were highly reflective, flat
corneal opacities in the anterior stroma accompanied by
focal deposits located in themidstroma.MCD caused general
increased reflectivity throughout the corneal stroma. The
deposits caused the irregularity of the anterior stromal border
from the epithelium side and the diffuse areas of hyperreflec-
tivity in Bowman’s layer. There was a noticeable flat layer
of increased reflectivity in the posterior, peripheral corneal
part. FECD caused corneal edema that was characterized
by irregularity of the posterior corneal border and corneal
epithelial and subepithelial bullae in advanced stages.
4. Discussion
According to the authors of the IC3D classification system
(the International Committee for Classification of Corneal
Dystrophies), understanding of corneal dystrophies is still
evolving due to the development of noninvasive imaging
techniques and introduction of genetic testing [26]. OCT
provides direct, noncontact, anterior eye segment imaging
allowing morphology and morphometry analysis. SS OCT
scans 360∘ around the anterior segment in 2.4 sec showed the
depth and extent of the pathologic corneal features. Good
repeatability and reproducibility of SS OCT anterior eye
segment measurements were proved in normal controls [27–
31]. Pachymetric maps made with SS OCT were compared
with a rotating Scheimpflug camera, ultrasound pachymetry,
specularmicroscopy, slit-scanning topography, TDOCT, and
830 nm SD OCT with high correlation rates [13, 17, 22–
27]. Fukuda et al. revealed that the CCT measured with
Scheimpflug camera was significantly larger than that mea-
sured with SS OCT, slit-scanning topography, and ultrasonic
pachymetry (𝑝 < .001) [28]. Fukuda et al. revealed that
CCTmeasured with SS OCTwas thinner compared with slit-
scanning topography (𝑝 < .001) and ultrasound pachymetry
(𝑝 < .001) [29]. The authors emphasize that CCT values
measured with different devices are not interchangeable.
Anterior chamber angle parameters such as TIA, TISA 500,
750 (trabecular iris space area at 500, 750 𝜇m from the scleral
spur) and AOD 500, 750 (angle opening distance at 500,
750𝜇m from the scleral spur) measurements repeatability,
reproducibility, and agreement between SS OCT and other
devices were studied in normal and glaucomatous eyes, but
no such studies have been conducted for opaque corneas [14–
16, 30, 31]. SS OCT demonstrated the high reproducibility of
angle analysis in healthy subjects.
Our study confirms the good agreement of CCTmeasure-
ments between devices in healthy subjects (aCCT, 𝑝 = .4;
mCCT, 𝑝 = .12). The ACD, nTIA, and tTIA measurements
differed significantly. ACD values measured with SS OCT
were significantly lower (mean difference = 0.07 ± 0.06mm;
𝑝 < .001). nTIA and tTIA measured with SS OCT were
significantly larger (mean difference = 1.58 ± 3.2∘; 𝑝 = .001;
mean difference = 2.22±2.91∘; 𝑝 < .001, resp.). Fukuda et al.,
who studied agreement of CCT, ACD, and anterior chamber
width measurements in 85 normal individuals between the
TDOCT and SS OCT prototype, also revealed no statistically
significant difference in CCT measurements. ACD measure-
ments were significantly different (𝑝 < .001); the mean
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Table 3: Statistical difference of anterior eye segment measurements: automated and manual central corneal thickness (aCCT, mCCT),
anterior chamber depth (ACD), and nasal and temporal trabecular iris angle (nTIA, tTIA) measurements by swept-source optical coherence
tomography SS OCT and time-domain optical coherence tomography TD OCT comparing different corneal dystrophies and normal eyes.
EBMD = epithelial basement membrane dystrophy, TBCD =Thiel-Behnke corneal dystrophy, LCD1 = lattice corneal dystrophy TGFBI type,
GCD1 = granular corneal dystrophy type 1, GCD2 = granular corneal dystrophy type 2, MCD = macular corneal dystrophy, and FECD =
Fuchs endothelial corneal dystrophy.
Statistical difference Study group versus normal controls
EBMD TBCD LCD GCD1 MCD FECD
aCCT
TD OCT p .89 p < .001 p < .001 p .82 p < .001 p < .001
U 292.5 U 17.5 U 144.5 U 166 U 6
SS OCT p .93 p < .001 p < .001 p .24 p < .001 p < .001
U 295.5 U 48.41 U 170.5 U 127.5 U 13
mCCT
TD OCT p .72 p < .001 p < .001 p .85 p < .001 p < .001
U 281.5 U 8 U 128 U 167.5 U 9.5
SS OCT p .77 p < .001 p < .001 p .84 p < .001 p < .001
U 284 U 20 U 94 U 167 U 4.5
ACD
TD OCT p .83 p .24 p .33 p .55 p .87 p < .001
U 288.5 U 106.5 U 335 U 150.5 U 562
SS OCT p .83 p .53 p .30 p .75 p .53 p < .001
U 288.5 U 126.5 U 324.5 U 159 U 51
nTIA
TD OCT p .93 p .06 p .69 p .25 p .98 p < .001
U 295.5 U 81 U 374 U 128.5 U 573.5
SS OCT p .84 p .07 p .70 p .12 p .49 p < .001
U 289 U 83.5 U 375 U 112 U 517
tTIA
TD OCT p .68 p .27 p .65 p .11 p .72 p < .001
U 277 U 109 U 370 U 110 U 545.5
SS OCT p .95 p .30 p .91 p .23 p .93 p < .001
U 297 U 111.5 U 393 U 126 U 568.5
difference was 0.04mm smaller compared to our study [28].
Aptel et al. studied CCT, ACD, TIA, TISA 500, 750, and
AOD 500, 750 measurements in healthy subjects. The study
revealed that ACD measured with SS OCT was significantly
larger (mean difference = 0.12 ± 0.08mm; 𝑝 < .001), and
the TIA measured with the SS OCT was significantly lower
(mean difference = 4.85∘ ± 5.30∘; 𝑝 < .01). There were
nonsignificant differences between the devices for the other
parameters (𝑝 > .06) [30]. The opposite results of the ACD
and TIA measurements found by Aptel et al. and our study
indicate that there is no systematic difference in ACD and
TIA measurements between TD and SS OCT, and the results
could vary depending on the device used for measurements.
To date, no comparison of CCT, ACD, and TIA mea-
surements with TD OCT and SS OCT has been published
for opaque corneas. Accurate pachymetric and angle mea-
surements in an eye with a corneal opacity are challenging
and of great importance in guiding treatment or retreatment
in corneal surgeries. Overestimation or underestimation in
anterior segment parameters could bemisleading in selecting
the corneal transplant type as well as deciding the depth
of treatment in phototherapeutic keratectomy. The 830 and
1310 nmOCTwas proved useful in the selection and planning
of surgical procedures to treat GCD by determining the size,
depth, and location of deposits [24, 32].We revealed that only
the mCCT showed good agreement between TD OCT and
SS OCT in the CDs group (𝑝 = .14). There were significant
differences for other studied parameters. That result should
be considered in clinical practice, while planning surgical
treatment in CD. It emphasizes the role of corneal manual
measurements in establishing the treatment plan.
Our study also indicated the impact of CD on corneal
pachymetry and anterior chamber parameters. TBCD, LCD,
and FECD caused increased aCCT and mCCT measured
with both devices compared to the control group. MCD was
characterized by significant corneal thinning, indicated by
previous studies [23, 33]. The increase in CCT is the main
feature of moderate and advanced FECD, but it is possible
that association with other anterior eye segment parameters
change is rarely examined. A link of FECD to axial hyperme-
tropia, shallow anterior chamber, and angle closure glaucoma
was suggested in the 1990s [34, 35], but another study
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Figure 3: Comparison of representative TD and SSOCT corneal scans in CD group.There are no differences in corneal deposits visualization
between both OCT systems. (a) TBCD: SS OCT pachymetry map showing the increase of CCT. aCCT of 612𝜇m. TD OCT high-resolution
corneal scan and SS OCT cornea scan showing increased reflectivity in the area of Bowman layer and anterior corneal stroma. The deposits
are causing the irregularity of the anterior stromal border from the epithelium side. (b) LCD: SS OCT pachymetry map showing the increase
of CCT. aCCT of 588 𝜇m. TDOCT high-resolution corneal scan and SS OCT cornea scan presenting diffuse areas of increased reflectivity in
the area of Bowman layer and anterior tomid stroma. (c)MCD: TDOCT pachymetrymap indicating corneal thinning with aCCT of 464𝜇m.
TD OCT high-resolution corneal scan and SS OCT cornea scan showing general increased reflectivity throughout the corneal stroma. Note
the irregularity of the anterior stromal border from the epithelium side and the diffuse areas of hyperreflectivity in Bowman’s layer. There is
a noticeable flat layer of increased reflectivity in the posterior, peripheral corneal part.
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found no significant difference in ACD between patients
and controls [36] and it was not further confirmed with
OCT studies. Our study indicated a significant increase in
CCT, thus indicating the advanced stage of FECD and the
significant decrease of ACD, nTIA, and tTIA in all 31 patients.
The significant ACD and TIA change probably is the result
of the increase in CCT, which was proved to be one factor
associated with narrow ACD and angle closure glaucoma in
the Beijing Eye Study 2006 [37].
Regarding CD corneal morphology analysis, our current
SS OCT study complements previous findings demonstrated
based on TD, SD, and SS OCT [19–23, 32, 33].
The weak part of our study was that including different
stages of the CD could affect the outcomes. On the other
side, due to the rarity and the individual course of the disease
among patients, further division of the study group into
subgroups would result in the insufficient number of subjects
for statistical analysis.
To conclude, better agreement between SS OCT and TD
OCTmeasurements was demonstrated in normal individuals
compared to the CDs group. Our study emphasizes the role
of manual measurements in establishing corneal thickness in
CDs. OCT provides comprehensive corneal deposits analysis
and demonstrates the association of CDwith CCT, ACD, and
TIA measurements.
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